Fort Point Capital Partners’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
– Sell
-1,300
Closed -$234K – 171
2017
Q3
$234K Buy
+1,300
New +$181K 0.11% 110

Fort Point Capital Partners's KITE Position: Q4 2017 in Review

Fort Point Capital Partners sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,300 shares — an estimated $234K sold.

Fort Point Capital Partners first reported a position in KITE in Q3 2017 and held it in 1 quarter. The position peaked at $234K in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Fort Point Capital Partners reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Fort Point Capital Partners sold 1,300 Kite Pharma, Inc. shares in Q4 2017, an estimated $234K.
  • Fort Point Capital Partners first reported a position in Kite Pharma, Inc. in Q3 2017 and held it in 1 quarter.
  • Fort Point Capital Partners's Kite Pharma, Inc. position peaked at $234K in Q3 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Fort Point Capital Partners's 13F filing for Q4 2017, filed 14 Feb 2018.